Julius Knowles Keros Therapeutics, Inc. (KROS) insider trading activity
Julius Knowles is of Keros Therapeutics, Inc.. Currently has a direct ownership of 1,191 shares of KROS, which is worth approximately $71,388. The most recent transaction as insider was on Apr 13, 2020, when has been sold 1,191 shares (Common Stock) at a price of $20.98 per share, resulting in proceeds of $24,987. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
1.19K
0%
3M change
0%
12M change
Total Value Held
$71,388
JK
Julius Knowles
Lexington, MA